Hydroxocobalamin is a prescription form of vitamin B12 used both for maintenance of B12 levels (for example in pernicious anemia or other causes of deficiency) and, in a different formulation, as an emergency intravenous antidote for cyanide poisoning (marketed as Cyanokit). The product appears as a 1000 mcg/mL injectable solution for intramuscular (IM) administration and as a 5 g powder for IV reconstitution for emergency use. Common adverse reactions reported across clinical sources include diarrhea, rash, itching and pain at the injection site; serious allergic reactions are described as rare.
This review synthesizes clinical guidance and product information from WebMD (patient-facing administration and monitoring notes), the Mayo Clinic (IV Cyanokit emergency use and supervision requirements), Drugs.com (formulation details: 1000 mcg/mL injectable solution and 5 g IV powder and timing of dermatologic effects) and StatPearls summaries of hydroxocobalamin. All claims here are drawn directly from those sources and cited in the research brief used to prepare this review.
High-level verdict: hydroxocobalamin is an effective and versatile parenteral vitamin B12 option and a recognized emergency cyanide antidote. Its strengths are clear formulation choices (IM solution for maintenance; 5 g IV powder for poisoning) and established clinical effects. Drawbacks are the need for clinician administration (IV use must be given by or under direct medical supervision), common local and dermatologic side effects including an acne-like rash that can appear 1–4 weeks post-treatment, and the requirement for laboratory follow-up during replacement therapy.
Does hydroxocobalamin reliably correct B12 deficiency and act as a cyanide antidote?
Clinical sources show hydroxocobalamin is an established form of vitamin B12 used to increase and maintain B12 levels in patients with pernicious anemia or other causes of deficiency; separate IV hydroxocobalamin (Cyanokit) is approved and used as an emergency antidote for known or suspected cyanide poisoning. Drugs.com explains the antidote effect: hydroxocobalamin helps convert cyanide into a form that can be excreted in urine.
For routine replacement, the IM injectable formulation provides a direct parenteral route when oral absorption is impaired. For acute cyanide exposure (smoke inhalation from closed-space fires, ingestion, or skin exposure), Mayo Clinic guidance is explicit that IV hydroxocobalamin must be given only by or under a doctor’s direct supervision because the situation is life‑threatening and requires immediate care.
What formulations are available and how are they supplied?
Product content listed in prescribing information and clinical references includes a 1000 mcg/mL injectable solution intended for intramuscular use and a 5 g powder for intravenous solution (the IV powder is the Cyanokit presentation specified for cyanide poisoning). These exact strengths are documented in the Drugs.com product summary and Mayo Clinic description.
The IM solution is the typical route for maintenance therapy in patients who cannot absorb oral B12; the 5 g IV powder is reserved for emergency cyanide treatment and is packaged to be reconstituted for IV administration in acute care settings under clinician supervision.
What side effects and safety precautions matter most?
Common adverse effects recorded across sources include diarrhea, rash, itching and injection-site pain. Drugs.com notes a distinctive acne-like skin rash can develop within 1 to 4 weeks after treatment and usually resolves without treatment; WebMD warns to keep scheduled lab appointments while on therapy. Serious allergic reactions are described as rare but possible; seek emergency care for hives, chest tightness, difficulty breathing or facial/throat swelling.
Because IV use is for life‑threatening cyanide poisoning, Mayo Clinic emphasizes it must be administered by or under the direct supervision of a physician. Patients receiving replacement therapy should expect clinician follow-up and laboratory monitoring as part of standard care.
How practical is administration for patients and clinicians?
For chronic B12 replacement clinicians typically use the IM 1000 mcg/mL solution; WebMD describes intramuscular administration and the need to maintain lab appointments during therapy. The parenteral route bypasses absorption issues but requires clinic visits or home nursing for injections, which affects convenience compared with oral supplements for patients who can absorb oral B12.
For emergency departments and ambulances, the 5 g IV powder (Cyanokit) is designed for rapid reconstitution and IV delivery in cyanide poisoning, but Mayo Clinic makes clear trained staff must supervise administration given the life‑threatening context.
What monitoring is recommended after treatment?
WebMD specifically advises patients to keep all appointments for laboratory work while using hydroxocobalamin; routine lab monitoring is standard when correcting deficiency to track hematologic and neurologic response. Clinical follow-up also allows assessment for persistent adverse effects like prolonged rash.
In emergency cyanide cases, post-treatment monitoring focuses on respiratory and cardiac stabilization and observation for adverse reactions. Because serious allergic events are rare but possible, facilities administering IV hydroxocobalamin should be prepared to manage hypersensitivity.
Pros & Cons
- ✅ Dual clinical roles: available as IM 1000 mcg/mL solution for B12 replacement and as a 5 g IV powder (Cyanokit) for emergency cyanide poisoning.
- ✅ Antidote mechanism: promotes conversion of cyanide to a form excreted in urine, per Drugs.com.
- ✅ Generally well tolerated: serious allergic reactions are described as rare across reviewed sources.
- ✅ Parenteral route bypasses absorption issues, useful for pernicious anemia and malabsorption where oral B12 is ineffective.
- ❌ Requires clinician administration for IV use — Mayo Clinic states the product must be given only by or under direct medical supervision.
- ❌ Common adverse effects include diarrhea, rash, itching and injection-site pain (reported across WebMD and Drugs.com).
- ❌ Acne-like skin rash can appear 1–4 weeks after treatment and may persist, per Drugs.com guidance.
How It Compares to the Competition
- Cyanocobalamin (injectable) — An alternative injectable form of vitamin B12 used for deficiency when absorbtion is the concern; different chemical form and commonly used for routine replacement.
- Cyanokit (hydroxocobalamin IV) — The specific 5 g IV powder formulation of hydroxocobalamin marketed for cyanide poisoning; equivalent emergency role but packaged for acute-care use.
- Hydroxy-Cobal (brand hydroxocobalamin) — Another brand-name hydroxocobalamin presentation intended for parenteral B12 therapy; similar clinical profile to Cobalin-H.
- Neo-Cytamen (brand hydroxocobalamin) — A branded hydroxocobalamin product with similar indications; choice among brands typically depends on hospital formulary and availability.
Who Should Buy This & Who Should Skip It
Buy it if: Patients with documented vitamin B12 deficiency who cannot absorb oral B12 (for example pernicious anemia) and require parenteral replacement should use hydroxocobalamin under prescription. Emergency departments and first‑response teams should stock the 5 g IV powder formulation (Cyanokit) for suspected cyanide poisoning, administered under physician supervision.
Skip it if: People who can reliably absorb and adhere to oral B12 supplements and prefer non‑injectable routes will generally be better served with oral cyanocobalamin or dietary measures. Individuals with prior severe allergic reactions to cobalamins should consult an allergist and their clinician before receiving hydroxocobalamin.
Search Purchase Options
Use these links to search for Clinical hydroxocobalamin injections (prescription) on trusted marketplaces. The links open in new tabs; if you buy through them, we may earn a commission at no extra cost to you.
* Affiliate links: you pay the same price either way.